How does Acoltremon actually make my eyes produce more tears?
Acoltremon activates special cold-sensing nerve endings (TRPM8 thermoreceptors) in your eye, which signal your tear glands to wake up and produce more tears. Phase 3 trials show this boost averages 40% above placebo over 12 weeks [1].
Your eye has tiny cold-sensing nerve endings called TRPM8 thermoreceptors scattered across the cornea and conjunctiva. When Acoltremon touches these nerve endings, it acts like a key turning on a switch. The COMET-2 and COMET-3 Phase 3 trials measured tear secretion in 1,200+ patients and found a consistent 40% increase compared to placebo [1].
Inside your eye, TRPM8 activation sends a signal up the trigeminal nerve—the same nerve that makes you blink when cold wind hits your face. This nerve message travels to your lacrimal gland (the tear factory behind your upper eyelid) and tells it to produce more tears. The result is a thicker, more stable tear film that coats your cornea and reduces the burning, grittiness, and blurred vision of dry eye [1].
The catch is timing: you won't feel relief on day one. Most patients notice improvement by week 2–3, with peak tear production by week 12. If you wear contact lenses, remove them 15 minutes before each drop and wait 15 minutes after to reinsert, because Acoltremon can stick to lens material and lose potency [2].
Start Acoltremon on a Monday morning so you can track your tear comfort over two weeks without weekend gaps. Keep a simple diary: rate your eye grittiness (1–10) each morning before the first drop. By week 3, you should see a clear downward trend [1].